XM does not provide services to residents of the United States of America.

Saudi king Salman recovers after undergoing medical tests, royal court says



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-Saudi king Salman recovers after undergoing medical tests, royal court says</title></head><body>

Adds background, paragraphs 2-5

DUBAI, Oct 9 (Reuters) -Saudi Arabia's King Salman has recovered after successfully completing medical tests for lung inflammation on Wednesday, the state news agency (SPA) said, citing the royal court.

The royal court said on Sunday the 88-year-old monarch would undergo medical tests for a lung inflammation.

The king of the world's biggest oil exporter and a major U.S. ally in the Middle East had received medical care for lung inflammation in May as well.

He last chaired a cabinet meeting on Sept. 24, state news agency reports (SPA) show, after issuing a royal decree in August that allows the cabinet to convene in the absence of both himself and the prime minister, his son Crown Prince Mohammed bin Salman.

Prince Mohammed offered reassurances about the health of the king at a cabinet meeting on Tuesday, state media reported.







Reporting by Nayera Abdallah; Editing by Andrew Heavens, William Maclean

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.